CDCA3 and cholangiocarcinoma: For liver cancer, recent reports have noticed the tumor-suppressive effects of miR-145-5p in either cholangiocarcinoma or HCC by targeting different mRNAs, like CDCA3, and SPATS2, and involved in cell proliferation, apoptosis, or metastasis [26, 27].